共 76 条
[1]
Andersen LK(2016)Prevalence of skin and skin-related diseases in the Rochester epidemiology project and a comparison with other published prevalence studies Dermatology 232 344-352
[2]
Davis MD(2018)Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study PLoS ONE 13 e0200683-1027
[3]
Calao M(2019)Association of hidradenitis suppurativa with inflammatory bowel disease: a systematic review and meta-analysis JAMA Dermatol 155 1022-419
[4]
Wilson JL(2017)Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States J Am Acad Dermatol 68 412-759
[5]
Spelman L(2016)Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): a cross-sectional reference study J Am Acad Dermatol 75 755-1292
[6]
Chen WT(2018)Hidradenitis suppurativa is associated with polycystic ovary syndrome: a population-based analysis in the United States J Invest Dermatol 138 1288-869
[7]
Chi CC(2019)PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens Br J Dermatol 181 866-194
[8]
Cosmatos I(1996)The prevalence of hidradenitis suppurativa and its potential precursor lesions J Am Acad Dermatol 35 191-749
[9]
Matcho A(2018)Psoriasis and hidradenitis suppurativa: a large-scale population-based study J Am Acad Dermatol 42 747-461
[10]
Weinstein R(2015)Questionnaire surveillance of hidradenitis suppurativa in Japan J Dermatol 233 456-1790